Connection

David Neskey to Molecular Targeted Therapy

This is a "connection" page, showing publications David Neskey has written about Molecular Targeted Therapy.
Connection Strength

0.174
  1. Immune Evasion by Head and Neck Cancer: Foundations for Combination Therapy. Trends Cancer. 2019 04; 5(4):208-232.
    View in: PubMed
    Score: 0.149
  2. Chk1/2 inhibition overcomes the cisplatin resistance of head and neck cancer cells secondary to the loss of functional p53. Mol Cancer Ther. 2013 Sep; 12(9):1860-73.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.